Arrow Electronics, Inc. (NYSE: ARW) is one of the world's largest electronic components and IT solutions distributors, founded in 1935 and headquartered in Centennial, Colorado. With ~21,520 employees and operations in over 50 countries, Arrow sits between electronic component manufacturers (TI, ST, ON Semi, Broadcom, etc.) and the end-customers — OEMs, contract manufacturers, and IT departments — that need those components and IT infrastructure products. Annual revenue of $30.85B in FY2025 places it among the 100 largest US companies by revenue.
Arrow operates through two segments: (1) Global Components (~63% of revenue) — distribution of electronic components including semiconductors, passive components, and embedded computing; and (2) Global Enterprise Computing Solutions (ECS) (~37% of revenue) — distribution and value-added resale of IT infrastructure including servers, storage, networking, security software, and cloud services. Both segments serve customers globally, with the components business most exposed to semiconductor inventory cycles.
The business is structurally a high-revenue, thin-margin model: gross margins run 11-13%, operating margins 2-4%, and the company earns roughly $0.03-0.04 per dollar of revenue. Value creation comes from scale, working capital management (accounts receivable financing, supplier terms), and the logistics and technical support layered on top of commodity distribution. Working capital swings drive FCF materially — in FY2025, a large AR build (+$6.3B) as revenue recovered post-destocking turned reported FCF negative despite solid EBIT. The FY2024 FCF of $1.04B was the result of working capital release during the destocking cycle. Investors must normalize FCF across cycles, not point-in-time.
Fiscal year ends December 31. Reports in USD. Interim President and CEO William F. Austen was confirmed by Business Wire on May 19, 2026; prior CEO Sean Kerins departed. New $1.0B share repurchase authorization announced May 12, 2026, signaling management confidence in valuation at current levels.
Investment Thesis
Arrow is a semiconductor inventory-cycle recovery play wrapped in a steady-state distribution compounder. After a painful 2023-2024 destocking period that cut revenue from the $37B peak (FY2022) to a trough, FY2025 revenue recovered to $30.85B (+10.5% YoY) with the cycle still not fully normalized. The forward consensus calls for continued recovery toward $34-36B as semiconductor inventory cycles restock and enterprise IT spending resumes.
Bull drivers: Semiconductor inventory destocking appears to have bottomed. BofA upgraded from Underperform to Neutral in April 2026 — a potential inflection signal from a historically skeptical house. The $1B buyback (authorized May 12) at ~10.1x forward P/E is likely accretive. Fwd P/E of 10.9x (FY2026E) is undemanding for a company with $11B market cap, $30B+ revenue, and a durable distribution moat. ECS segment benefits from sustained enterprise cloud/AI infrastructure spending (server, storage, networking). Working capital normalization should convert to strong FCF in FY2026 as the AR build reverses.
Key risks: Gross margin structural compression from competition with Avnet, TD Synnex, and direct-from-fab programs. CEO transition uncertainty — interim leadership creates strategic ambiguity. Cyclical — a second-derivative deceleration in semiconductor demand would hit again. FCF is lumpy due to working capital; FY2025 FCF was -$37M on large AR build. Wells Fargo maintains Underweight, citing margin pressure and cycle timing uncertainty. Consensus PT ($208.33 avg) sits below the current price of $217.33, suggesting limited near-term upside on consensus numbers.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $28,921M | $37,124M | $33,107M | $27,921M | $30,853M |
| Revenue Growth | +28.9% | +28.4% | -10.8% | -15.7% | +10.5% |
| Gross Profit | $3,575M | $4,517M | $4,056M | $3,335M | $3,447M |
| Gross Margin | 12.4% | 12.2% | 12.2% | 11.9% | 11.2% |
| Operating Income | $1,215M | $1,607M | $1,244M | $800M | $929M |
| Operating Margin | 4.2% | 4.3% | 3.8% | 2.9% | 3.0% |
| EBITDA | $1,372M | $1,806M | $1,418M | $960M | $1,072M |
| EBITDA Margin | 4.7% | 4.9% | 4.3% | 3.4% | 3.5% |
| Net Income | $843M | $1,126M | $752M | $376M | $571M |
| EPS (Diluted) | $9.84 | $15.76 | $11.24 | $6.29 | $10.93 |
| Interest Expense | $181M | $241M | $363M | $356M | $331M |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & ST Investments | $337M | $261M | $258M | $361M | $432M |
| Accounts Receivable | $8,455M | $9,601M | $9,103M | $6,997M | $9,344M |
| Total Current Assets | $14,327M | $17,104M | $16,076M | $11,803M | $14,895M |
| Total Assets | $19,207M | $22,358M | $21,015M | $15,984M | $19,657M |
| Total Debt | $3,382M | $3,673M | $3,729M | $2,953M | $3,073M |
| Net Debt | $3,045M | $3,412M | $3,471M | $2,592M | $2,641M |
| Stockholders' Equity | $5,710M | $6,316M | $6,499M | $5,947M | $6,575M |
| Current Ratio | 1.97x | 2.01x | 1.97x | 1.92x | 1.95x |
| Net Debt / EBITDA | 2.2x | 1.9x | 2.4x | 2.7x | 2.5x |
| Book Value / Share | $66.6 | $88.4 | $97.3 | $99.6 | $128.6 |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$2,119M | -$1,023M | $678M | $1,121M | -$14M |
| Capital Expenditures | -$103M | -$124M | -$97M | -$82M | -$100M |
| CapEx % of Revenue | 0.4% | 0.3% | 0.3% | 0.3% | 0.3% |
| Free Cash Flow | -$2,222M | -$1,147M | $581M | $1,039M | -$114M |
| Share Repurchases | -$605M | -$1,112M | -$450M | -$507M | -$484M |
| Net Debt Change | +$1,066M | +$291M | +$56M | -$776M | +$120M |
| Dividends Paid | $0M | $0M | $0M | $0M | $0M |
| Multiple | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| P/E Ratio | 22.1x | 13.8x | 19.3x | 34.6x | 19.9x |
| P/S Ratio | 0.38x | 0.30x | 0.34x | 0.40x | 0.36x |
| P/B Ratio | 3.26x | 1.79x | 1.68x | 2.18x | 1.69x |
| P/FCF Ratio | N/M (neg) | N/M (neg) | 19.1x | 10.7x | N/M (neg) |
| EV/EBITDA | 10.4x | 8.2x | 10.0x | 14.4x | 13.0x |
| EV/Sales | 0.49x | 0.39x | 0.43x | 0.49x | 0.45x |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Return on Equity | 14.8% | 17.8% | 11.6% | 6.3% | 8.7% |
| Return on Assets | 4.4% | 5.0% | 3.6% | 2.4% | 2.9% |
| ROIC | 10.3% | 11.6% | 7.5% | 4.2% | 5.2% |
| Asset Turnover | 1.50x | 1.66x | 1.57x | 1.75x | 1.57x |
| Gross Margin | 12.4% | 12.2% | 12.2% | 11.9% | 11.2% |
| Operating Margin | 4.2% | 4.3% | 3.8% | 2.9% | 3.0% |
| Interest Coverage | 6.7x | 6.7x | 3.4x | 2.2x | 2.8x |
| Days Sales Outstanding | 107d | 94d | 100d | 91d | 111d |
| Metric | FY2025A | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|
| Revenue (Avg) | $30,853M | $32,853M | $34,699M | $36,155M |
| Rev Growth | +10.5% | +6.5% | +5.6% | +4.2% |
| EPS (Avg) | $10.93 | $19.97 | $21.53 | $25.04 |
| EPS Growth | +73.8% | +82.7% | +7.8% | +16.3% |
| # Analysts (EPS) | — | 6 | 6 | 4 |
| Fwd P/E | 19.9x | 10.9x | 10.1x | 8.7x |
| Name | Title | Type | Shares | Price | Date |
|---|---|---|---|---|---|
| Lamercie Jean-Claude Carine | SVP, Chief Legal & Compliance Officer / Secretary | Sale | 3,000 | $216.00 | May 22, 2026 |
| Zech Gretchen | SVP, Chief Gov / Sustainability / HR Officer | Sale | 16,000 | $212.08 | May 21, 2026 |
| Nowak Eric | President, Global ECS | Sale | 3,473 | $210.99 | May 21, 2026 |
| Hayford Andrew C | Director | Award (DSU) | — | $0.00 | May 18, 2026 |
| Lowe Janet | Director | Award (DSU) | — | $0.00 | May 18, 2026 |
| Gunby Stephen C | Director | Award (DSU) | — | $0.00 | May 18, 2026 |
Semiconductor inventory cycle is in the early innings of recovery. The FY2024 destocking trough compressed Arrow's EPS from $15.76 (FY2022) to $6.29 (FY2024). The consensus calls for $19.97 EPS in FY2026 — above the prior peak. If semiconductor demand fully normalizes and the AI-driven capex cycle translates into component orders (IoT, industrial AI, edge compute), revenue could exceed $35B with margin improvement, putting EPS closer to $22-25.
$1B buyback at 10.9x forward P/E is highly accretive. At current prices, the May 12 buyback authorization represents ~9% of market cap. Buying back ~9% of shares at 10-11x forward earnings is one of the most value-creating uses of capital available to Arrow — particularly with normalized FCF recovering toward $600M+ in FY2026.
ECS segment is structurally exposed to enterprise AI infrastructure. Servers, networking, storage, and cloud services supporting AI workloads are all Arrow ECS distribution territory. AI capex tailwind (hyperscalers, enterprise) is the most durable demand driver in IT spending — less cyclical than components.
BofA upgrade from Underperform to Neutral (April 2026) signals inflection. BofA has been one of the more skeptical voices — a move to neutral after extended underperformance coverage suggests the downside is better-defined and the recovery case is becoming more credible to institutional investors.
12-month bull case: $265 (+22%) — consensus EPS $19.97 x 13.3x P/E (still a discount to the distribution sector average), with working capital normalization releasing $600-700M FCF vs FY2025 negative.
The stock is at a 52-week high with consensus PT below current price. At $217.33 vs an average PT of $208.33, the market is pricing in outcomes above what sell-side consensus models. Buying near the 52-week high when analysts are saying "hold" embeds multiple-expansion risk with no obvious catalyst timing.
Gross margin compression is secular, not cyclical. Arrow's gross margin has fallen from 12.4% (FY2021) to 11.2% (FY2025) — a 120bps decline over 4 years driven by manufacturers extending direct-from-fab programs, customers consolidating distributors, and competition from Avnet and TD Synnex. A further 50-100bps compression would erode $150-300M of annual gross profit even with revenue recovery.
CEO transition risk. Interim CEO William Austen provides continuity but not strategic momentum. Any material strategy change, acquisition announcement, or negative guidance could spook the market disproportionately without a permanent CEO anchoring investor expectations. The prior CEO departure is unexplained in public filings.
Working capital reversal is not guaranteed. If the semiconductor recovery stalls — China export controls tightening, macro deterioration — the FY2025 AR build will not release cleanly, and FCF will remain negative for a second year. At 19.9x TTM P/E, there is no cushion for a miss.
Wells Fargo Underweight is the bear anchor. Their model likely prices in weaker gross margin recovery and slower ECS growth — if correct, the $208 consensus PT holds or slips further as the EPS recovery takes longer than modeled. 12-month bear case: $155 (-29%) — Wells Fargo PT, implying 7.8x FY2026E EPS if cycle re-slows.
Manufacturers extending direct-from-fab programs (TI, AVGO, Murata) and customers consolidating distributor relationships create secular pressure on Arrow's 11-13% gross margin. Each 100bps compression = ~$300M gross profit loss. Distribution is inherently a commodity service — Arrow must add value-add services (design-in, supply chain finance, ECS integration) faster than the spread narrows.
The 2023-2024 destocking cycle cut revenue 25% and EPS 60% from peak. If the current recovery stalls — from macro weakness, China-US trade escalation, or AI capex deceleration — Arrow faces another inventory glut. With DSO at 111 days and AR at $9.3B, a demand slowdown would both impair revenue and require working capital write-downs, creating a double-negative earnings impact.
Interim CEO William Austen creates strategic uncertainty. The circumstances of Sean Kerins' departure are not fully public. A protracted search for a permanent CEO (6-12 months is common) suppresses multiple expansion and increases the probability of strategic drift or reactive decision-making during a critical cycle-recovery window. Insider selling cluster near 52-week highs amplifies governance concerns.
Arrow's $9.3B AR balance (FY2025) means FCF is non-linear across years. The FY2025 -$114M FCF vs FY2024 +$1.04B FCF demonstrates how dramatically working capital can swing reported results. Investors who anchor on annual FCF without normalizing for the cycle can dramatically mis-price the stock. Cycle-normalized FCF of ~$500M is the right signal, not any single year.
Arrow derives a significant portion of revenue from Asia-Pacific operations and globally-sourced components. US-China trade escalation, export controls on advanced semiconductors, and tariff regimes can disrupt supply chains, create customer uncertainty on ordering, and reduce gross spreads as Arrow absorbs cost pass-through friction. The 2024 export control expansion is an active ongoing risk.
Interest coverage of 2.8x (FY2025) is adequate but leaves limited cushion if EBIT declines. Total debt of $3.1B at ~7% weighted avg cost generates ~$220M annual interest expense. If EBIT contracts 30% from a demand shock (plausible given FY2022→2024 history), coverage falls below 2x — a level that constrains buyback capacity and elevates refinancing risk on the revolving credit facility.
FY2026 EPS of $19.97 materializes on schedule. Working capital normalization releases $600-700M FCF, funding buybacks. Stock rerates to 13.3x forward P/E as the cycle recovery is confirmed and a permanent CEO is named. BofA joins Raymond James in upgrading to Buy. EV/EBITDA expands toward 11x on higher EBITDA. Gross margin stabilizes at 11.5%.
Tracks consensus PT of $208. Revenue grows 6-7% in FY2026, EPS recovery partially realized at $17-19. Multiple stays roughly flat at 10-11x forward. CEO search extends 6-9 months — no re-rating catalyst but no deterioration. FCF recovery to $400-500M vs FY2025 negative. Stock consolidates near current level.
Wells Fargo bear case. Semiconductor demand recovery stalls — China export controls escalate, macro deteriorates. Gross margin falls another 50bps to 10.7%. FY2026 EPS disappoints at $14-16 vs $19.97 consensus. AR remains elevated; FCF stays near zero. Multiple compresses to 9-10x forward. CEO transition creates board friction. Target: 7.8x FY2026E EPS on revised lower consensus = $155.
This report was generated using FMP financial data as of May 23, 2026. This is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.